Recent developments in neurochemical imaging in schizophrenia: an update

Area of Science:

• Neuroscience
• Psychiatry
• Medical Imaging

Background:

• Neurochemical brain imaging methods enable the study of human brain development and neurochemistry.
• Schizophrenia research benefits from advancements in visualizing neurotransmitter systems.

Purpose of the Study:

• To provide an update on recent developments in neurochemical imaging for schizophrenia research.
• To review major findings concerning dopamine, serotonin, and glutamate in schizophrenia.

Main Methods:

• Utilizing advanced radioligands for neuroreceptor imaging, such as [(11)C]PHNO for dopamine D(2)/D(3) receptors.
• Employing selective radiotracers like [(11)C]DASB for imaging the serotonin transporter (SERT) via positron emission tomography (PET).
• Applying in vivo magnetic resonance spectroscopy (MRS) at high magnetic field strengths.

Main Results:

• [(11)C]PHNO shows higher affinity for D(3) than D(2) receptors and can model dopaminergic alterations in schizophrenia by measuring amphetamine-induced dopamine release.
• Selective tracers enable PET imaging of the serotonin transporter (SERT).
• The glutamatergic hypothesis is progressing towards clinical trials with novel agents.

Conclusions:

• Neurochemical imaging, particularly with novel radioligands and MRS, offers significant potential for advancing schizophrenia research.
• Continued development in imaging techniques will enhance our understanding of neurochemical imbalances in schizophrenia.